Switching From Oral Dopamine Agonists to Rotigotine
Condition(s):Restless Legs Syndrome; Ekbom Syndrome; Willis-Ekbom DiseaseLast Updated:November 29, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Restless Legs Syndrome; Ekbom Syndrome; Willis-Ekbom DiseaseLast Updated:November 29, 2016Completed
Condition(s):Restless Legs Syndrome; End Stage Renal Disease; Hemodialysis; Muscle Cachexia; Sleep DisordersLast Updated:July 5, 2010Completed
Condition(s):Parkinson’s DiseaseLast Updated:January 27, 2015Unknown status
Condition(s):Parkinson DiseaseLast Updated:September 8, 2014Completed
Condition(s):Parkinson DiseaseLast Updated:March 19, 2009Completed
Condition(s):Pituitary Neoplasms; AdenomaLast Updated:January 20, 2023Recruiting
Condition(s):Hyperprolactinemia; ProlactinomaLast Updated:July 30, 2021Completed
Condition(s):Parkinson’s DiseaseLast Updated:October 31, 2014Completed
Condition(s):Parkinson’s DiseaseLast Updated:May 12, 2017Completed
Condition(s):Invasive Prolactinomas Involving the Cavernous SinusLast Updated:May 16, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.